- Home
- Publications
- Publication Search
- Publication Details
Title
Drugs in Development for Relapsing Multiple Sclerosis
Authors
Keywords
Multiple Sclerosis, Expand Disability Status Scale, Progressive Multifocal Leukoencephalopathy, Alemtuzumab, Natalizumab
Journal
DRUGS
Volume 73, Issue 7, Pages 625-650
Publisher
Springer Nature
Online
2013-04-23
DOI
10.1007/s40265-013-0030-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CNS vasculitis in a patient with MS on daclizumab monotherapy
- (2013) J. Ohayon et al. NEUROLOGY
- Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial
- (2012) William Stohl et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis
- (2012) Ernst-Wilhelm Radue ARCHIVES OF NEUROLOGY
- Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis
- (2012) T. Komiya et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rituximab and Multiple Sclerosis
- (2012) Dimitrios K. Kitsos et al. CLINICAL NEUROPHARMACOLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial
- (2012) David H Miller et al. LANCET NEUROLOGY
- Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
- (2012) Christian Confavreux et al. Multiple Sclerosis Journal
- Teriflunomide added to interferon- in relapsing multiple sclerosis: A randomized phase II trial
- (2012) M. S. Freedman et al. NEUROLOGY
- Alemtuzumab more effective than interferon -1a at 5-year follow-up of CAMMS223 Clinical Trial
- (2012) A. J. Coles et al. NEUROLOGY
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial
- (2011) W. Rigby et al. ARTHRITIS AND RHEUMATISM
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Proteinuria with fumaric acid ester treatment for psoriasis
- (2011) S. Ogilvie et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis
- (2011) Roland Martin CLINICAL IMMUNOLOGY
- Immune mechanisms of new therapeutic strategies in MS — Teriflunomide
- (2011) Malte C. Claussen et al. CLINICAL IMMUNOLOGY
- A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis
- (2011) E. J. Fox et al. EUROPEAN JOURNAL OF NEUROLOGY
- Mitoxantrone exerts both cytotoxic and immunoregulatory effects on activated microglial cells
- (2011) Jun-Min Li et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Recent insights into the mechanism of action of glatiramer acetate
- (2011) Mrinalini Kala et al. JOURNAL OF NEUROIMMUNOLOGY
- Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
- (2011) Grant A Hill-Cawthorne et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis
- (2011) Per Soelberg Sørensen JOURNAL OF THE NEUROLOGICAL SCIENCES
- Insight into the mechanism of laquinimod action
- (2011) W. Brück et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
- (2011) Alasdair J Coles et al. LANCET NEUROLOGY
- Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
- (2011) Bhupendra Khatri et al. LANCET NEUROLOGY
- Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
- (2011) Ludwig Kappos et al. LANCET NEUROLOGY
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study
- (2011) Ludwig Kappos et al. Multiple Sclerosis Journal
- A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design
- (2011) Edward Fox et al. Multiple Sclerosis Journal
- A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy
- (2011) Simone C Wuest et al. NATURE MEDICINE
- Intrathecal effects of daclizumab treatment of multiple sclerosis
- (2011) B. Bielekova et al. NEUROLOGY
- Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
- (2011) V. Martinelli et al. NEUROLOGY
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
- (2010) F. Morschhauser et al. ANNALS OF ONCOLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- Alemtuzumab and multiple sclerosis: therapeutic application
- (2010) Minagar Alireza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
- (2010) Christiane Wegner et al. JOURNAL OF NEUROIMMUNOLOGY
- Laquinimod suppress antigen presentation in relapsing–remitting multiple sclerosis: In-vitro high-throughput gene expression study
- (2010) M. Gurevich et al. JOURNAL OF NEUROIMMUNOLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate
- (2010) C. Ford et al. Multiple Sclerosis Journal
- Fingolimod is a potential novel therapy for multiple sclerosis
- (2010) Orhan Aktas et al. Nature Reviews Neurology
- Tratamiento oral con laquinimod en la esclerosis múltiple
- (2010) O. Fernández NEUROLOGIA
- Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- (2010) J. J. Marriott et al. NEUROLOGY
- Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
- (2010) R. T. Naismith et al. NEUROLOGY
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term B-Lymphocyte Depletion With Rituximab in Patients With Relapsing-Remitting Multiple Sclerosis
- (2009) Olaf Stüve et al. ARCHIVES OF NEUROLOGY
- Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
- (2009) Unsong Oh et al. ARCHIVES OF NEUROLOGY
- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
- (2009) Bibiana Bielekova et al. ARCHIVES OF NEUROLOGY
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Rediscovering alemtuzumab: current and emerging therapeutic roles
- (2009) John G. Gribben et al. BRITISH JOURNAL OF HAEMATOLOGY
- Melanoma following treatment with alemtuzumab for multiple sclerosis
- (2009) A. A. Pace et al. EUROPEAN JOURNAL OF NEUROLOGY
- Ocrelizumab: a step forward in the evolution of B-cell therapy
- (2009) Fariha Kausar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation
- (2009) C. Chen et al. JOURNAL OF IMMUNOLOGY
- Monoclonal antibodies in the therapy of multiple sclerosis
- (2009) P. S. Rommer et al. JOURNAL OF NEUROLOGY
- Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis
- (2009) Jean E. Merrill et al. JOURNAL OF NEUROLOGY
- Estrogen treatment in multiple sclerosis
- (2009) Stefan M. Gold et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Atacicept bei Multipler Sklerose
- (2009) H.-P. Hartung NERVENARZT
- Safety profile of Tysabri: international risk management plan
- (2009) P. Iaffaldano et al. NEUROLOGICAL SCIENCES
- Mitoxantrone: benefits and risks in multiple sclerosis patients
- (2009) V. Martinelli et al. NEUROLOGICAL SCIENCES
- Mitoxantrone and cytotoxic drugs' mechanisms of action
- (2009) T. Vollmer et al. NEUROLOGY
- Monoclonal antibodies in MS: Mechanisms of action
- (2009) B. Bielekova et al. NEUROLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Leflunomide-Associated Progressive Multifocal Leukoencephalopathy
- (2008) Megan Rahmlow et al. ARCHIVES OF NEUROLOGY
- Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Rituximab: Beyond Simple B Cell Depletion
- (2008) A. Kessel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- A review of the current use of rituximab in autoimmune diseases
- (2008) Hakan M. Gürcan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis
- (2008) C. L. Hirst et al. JOURNAL OF NEUROLOGY
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Getting specific: monoclonal antibodies in multiple sclerosis
- (2008) Andreas Lutterotti et al. LANCET NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now